[American Thoracic Society American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX - ()] A102. COPD: THERAPY - Reduction in the Risk of All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol Compared to Umeclidinium/Vilanterol in IMPACT Including Previously Missing or Censored Vital Status Data
Lipson, D.A., Criner, G.J., Day, N., Dransfield, M.T., Halpin, D.M.G., Han, M.K., Jones, C.E., Kilbride, S., Lange, P., Lomas, D.A., Manchester, P., Martinez, F.J., Midwinter, D., Morris, A.N., PascoeLanguage:
english
DOI:
10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A7344
File:
PDF, 84 KB
english